IE 11 is not supported. For an optimal experience visit our site on another browser.
  • UP NEXT

    Covid-19 is ‘still extracting a price' despite lower death rates, infectious disease expert says

    04:55
  • Full Panel: 'Relationships matter' for GOP leaders ahead of 2024

    07:45
  • GOP congressman is ‘opposed to the removal’ of Rep. Omar from House Foreign Affairs Committee

    06:55
  • Memphis PD to release video of Tyre Nichols' arrest after officers charged

    03:54
  • ‘Toxic police culture’ causes ‘avoidable deaths,’ retired NYPD detective says

    06:23
  • Video of Tyre Nichols’ beating is ‘horrific’ and ‘alarming’: Memphis Police Chief

    04:13
  • Elon Musk meets with House Republicans

    02:09
  • Understanding what occurs in bodycam footage from Paul Pelosi hammer attack

    02:54
  • How mixed messages on the economy could impact your wallet

    02:35
  • Docuseries examines Minneapolis high school football team coached by current, former police officers

    04:53
  • Russia steps up missile attacks on Kyiv as Ukraine prepares to receive western tanks

    03:42
  • How video showing fatal beating of Tyre Nichols could impact former officers’ defense

    05:18
  • Illinois Holocaust Museum preserves survivors' stories through virtual reality

    06:52
  • As NASA looks ahead to Mars the agency remains remembering its past

    03:51
  • AI technology helps families identify relatives in images from Holocaust

    04:19
  • Officials make arrests in fake nursing school diploma scheme 

    03:02
  • Taxi and Uber drivers clash at Cancun airport

    02:56
  • Wisconsin woman wakes up to carjacking while in backseat

    02:10
  • Meta executive lays out 'guardrails' for Trump's possible return to Instagram, Facebook

    03:41
  • National Archives asking all presidents to 'conduct an assessment' for classified materials

    03:16

Merck's antiviral Covid pill approved by U.K. regulator

02:36

The United Kingdom's medicine regulator has approved Merck's antiviral pill to treat symptomatic Covid-19 infections. NBC News' Matt Bradley speaks about how the U.K. came to this decision and when approval could be expected in the United States.